Clinical Trial Update: Impact of a Dolutegravir-based Regimen on Early Mortality of AIDS Patients [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating a dolutegravir-based regimen showed results in severely immunocompromised HIV patients, with completed Phase 2 and Phase 3 studies a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome

Drugs mentioned

• Dolutegravir (dolutegravir)
• Dolutegravir-based regimen (dolutegravir)

Snippet

Sponsor: Fundação Bahiana de Infectologia | Conditions: Severely Immunocompromised HIV Patients | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-12-14